ENSYSCE BIOSCIENCES, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ENSYSCE BIOSCIENCES, INC. payments for repurchase of common stock for the quarter ending 2020-03-31 was $136.28M.
- ENSYSCE BIOSCIENCES, INC. payments for repurchase of common stock for fiscal 2020 was $184.78M, a 1495.17% increase from fiscal 2019.
- ENSYSCE BIOSCIENCES, INC. payments for repurchase of common stock for fiscal 2019 was $11.58M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2020-12-31 | $184.78M 10-K/A · filed 2021-06-08 | |
| 2020-03-31 | $136.28M 10-Q · filed 2021-06-08 | |
| 2019-12-31 | $11.58M 10-K/A · filed 2021-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |